ClinicalTrials.gg
Sign In

Disease Progression clinical trials

The registry lists 402 studies for Disease Progression across more than 10 countries. 112 are recruiting or about to start. 31 of them are mainly about Disease Progression (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Pathologic Complete Response: 585 studies, 183 open.

Get an email when these change. Save the Disease Progression studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
163
Recruiting
74
Status unknown
63
Not yet recruiting
35
Active, not recruiting
28
Terminated
19

Phase

Phase 2
64
Phase 1
36
Phase 3
22
Phase 4
14
Early Phase 1
1

Where

United States
121
China
50
France
33
Germany
32
Italy
26
United Kingdom
23

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (12) · National Cancer Institute (NCI) (11) · Assistance Publique - Hôpitaux de Paris (6) · Peking Union Medical College Hospital (5) · Mansoura University (5) · University of Zurich (5) · Radboud University Medical Center (5) · M.D. Anderson Cancer Center (5)

What is being tested here

Drugs under test in Disease Progression studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Colchicine202
Capivasertib122
Ublituximab102
Rituximab101
Immunoglobulins, Intravenous101
Immunoglobulin G101
Sacituzumab tirumotecan101
Thioctic Acid101
Regorafenib101
Cemiplimab101

Drug classes tested here Antimitotic agents 3 open · Tyrosine kinase inhibitors (TKIs) 1 open · Immune checkpoint inhibitors 1 open · Proteasome inhibitors 5 · Reverse transcriptase inhibitors 5

Coming up

3phase 3 studies under way
26studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 74 Disease Progression studies recruiting now, 42 (57%) set no upper age limit and 16 (22%) stop at 75 or younger. 7 (9%) take children under 18. 3 (4%) are for women only and 2 (3%) for men only; 17 (23%) take healthy volunteers.

Recruiting studies that take each age, of 74
AgeWomenMen
104 (5%)4 (5%)
1862 (84%)61 (82%)
3064 (86%)62 (84%)
4065 (88%)64 (86%)
5068 (92%)67 (91%)
6566 (89%)65 (88%)
7562 (84%)62 (84%)
8552 (70%)52 (70%)

Across all 402 studies, recruiting or not: 18% stop at 75 or younger and 11% at 65; 20% take children; 5% are for women only and 2% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Disease Progression studies take

Of 108 observational studies under Disease Progression, half reached primary completion within 68 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase62 mo23–74 · 32 studies——
Observational68 mo35–153 · 108 studies—67 mo35–153 · 103 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 402. Browse all 402 → or search them.